fingolimod hydrochloride
PolandDrugs containing this active substance
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS). It helps to reduce the number of disease relapses and slow the progression of disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AE01
Manufacturer: G.L. Pharma GmbH, Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS). It helps to reduce the number of disease relapses and slow down the progression of disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AA27
Manufacturer: Ardena Pamplona S.L. Krka, d.d., Novo mesto
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), especially in individuals for whom other treatments have not worked or in whom the disease is progressing rapidly and severely.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AE01
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing forms of multiple sclerosis (MS), particularly in individuals for whom previous treatment has not been effective or in patients with a rapidly progressing, severe form of the disease. It helps to reduce the number of relapses and slow the progression of disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AE01
Manufacturer: Adamed Pharma S.A.
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing forms of multiple sclerosis (MS), especially in people for whom other treatments have not been effective or in whom the disease is progressing rapidly and severely.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AE01
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica, S.A.
-
The medicine is intended for adult patients with relapsing-remitting multiple sclerosis (MS), particularly in individuals for whom previous treatment has not been effective or in whom the disease is progressing rapidly and severely. It helps to reduce the number of relapses and slow the progression of disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AA27
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), particularly in individuals for whom other treatments have not been effective or in whom the disease is progressing rapidly and severely.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AA27
Manufacturer: Betapharm Arzneimittel GmbH
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS). It helps to reduce the number of disease relapses and slow the progression of disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AA27
Manufacturer: Synthon B.V., Synthon Hispania S.L.
-
The medicine is used in adults and children and adolescents (over 10 years of age with a body weight over 40 kg) for the treatment of relapsing-remitting multiple sclerosis (MS), especially in individuals for whom treatment is ineffective or in patients with a rapidly progressing, severe form of the disease. It helps to reduce the number of relapses and slow the progression of disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AE01
Manufacturer: Centrafarm Services B.V.
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing forms of multiple sclerosis (MS), particularly in individuals who have not responded to other treatments or who have a rapidly progressing, severe form of the disease.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.28 mg ATC: L04AE01
Manufacturer: Balkanpharma-Dupnitsa AD Merckle GmbH Teva Netherlands B.V. Teva Operations Poland Sp. z o.o.
-
The medicine is used in adults as well as children and adolescents (over 10 years of age) for the treatment of relapsing forms of multiple sclerosis (MS), particularly in individuals who have not responded to other treatments or who have a rapidly progressing, severe form of the disease.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AE01
Manufacturer: Balkanpharma-Dupnitsa AD Merckle GmbH Teva Netherlands B.V. Teva Operations Poland Sp. z o.o.
-
The medicinal product is used in adults and children and adolescents (over 10 years of age and weighing more than 40 kg) for the treatment of relapsing-remitting multiple sclerosis (MS). It helps to reduce the number of disease relapses and slows the progression of disability.
Form: capsules, hard
Active substance Dosage fingolimod 0.5 mg fingolimod hydrochloride 0.56 mg ATC: L04AE01
Manufacturer: Labormed-Pharma S.A. S.C. Zentiva S.A.
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), particularly in individuals for whom other medicines have not worked or in whom the disease is progressing rapidly and severely.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AE01
Manufacturer: Bausch Health Poland Sp. z o.o.
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), especially in individuals for whom previous treatment has not been effective or in patients with a rapidly progressing, severe form of the disease. It helps to reduce the number of relapses and slow the progression of disability.
Form: capsules, hard
Active substance Dosage fingolimod 0,50 mg fingolimod hydrochloride 0.56 mg ATC: L04AA27
Manufacturer: neuraxpharm Arzneimittel GmbH, PRASFARMA, S.L.
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), especially in individuals for whom other treatments have not worked or in whom the disease is progressing rapidly and severely.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.28 mg ATC: L04AA27
Manufacturer: Novartis Pharma GmbH